Curatia Medical Ltd, a vascular interventional therapy developer with operations in Silicon Valley, California, and Suzhou, China, has reportedly raised tens of millions of renminbi in its latest financing round, co-led by Hidea Investment.
Company Background
Founded in 2015, Curatia specializes in biomaterials, machinery, coatings, metal weaving, extrusion, abrasives, and other technologies. The company has developed 16 commercialized medical products and has sold over 5 million catheters in the US, Germany, South Korea, Poland, and more than 30 other markets.
Funding and Future Prospects
The recent funding round will support Curatia’s ongoing development and commercialization efforts, further expanding its global reach in the vascular interventional therapy market.-Fineline Info & Tech
